At Revolution Health , we guide patients safely through their weight loss journey, combining medication, nutrition, and lifestyle for comprehensive results
Ashley Mayer, a general partner at Coalition Operators who led its Shotsy investment, said the most important thing Shotsy can do now is create a product that users love
As clinical data for both anti-PCSK9 antibodies and GLP-1 analogue molecules are widely available, we used PK-PD modelling to determine the appropriate potency at human GLP-1R for the fusion molecule that should deliver robust glucose control without inducing non-manageable GLP-1 driven adverse events at exposure levels able to efficiently neutralize PCSK9
[1] Since then, it has become one of the most studied hormones in metabolic medicine and the biological basis for some of the most talked-about diabetes and weight-loss drugs in the world, like Ozempic
Whilst there is no universal guidance mandating routine B12 monitoring specifically for GLP-1/GIP users, clinical judgement should guide individualised monitoring